Judith M. Matthews Iterum Therapeutics PLC (ITRM) insider trading activity

Judith M. Matthews is Chief Financial Officer of Iterum Therapeutics plc. Currently has a direct ownership of 8,135 shares of ITRM, which is worth approximately $10,575. The most recent transaction as insider was on Mar 11, 2023, when has been sold 2,883 shares (Ordinary Shares) at a price of $0.96 per share, resulting in proceeds of $2,767. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 8.14K

0% 3M change

0% 12M change

Total Value Held $10,575

Judith M. Matthews Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 11 2023	SELL Payment of exercise price or tax liability	$2,767 $0.96 p/Share	2,883 Reduced 26.17%	8,135 Ordinary Shares
Mar 11 2023	BUY Grant, award, or other acquisition	-	6,666 Added 37.7%	11,018 Ordinary Shares
Mar 14 2022	SELL Open market or private sale	$17,910 $0.38 p/Share	47,132 Reduced 36.64%	81,500 Ordinary Shares
Mar 11 2022	BUY Grant, award, or other acquisition	-	100,000 Added 43.74%	128,632 Ordinary Shares
Jan 26 2021	SELL Open market or private sale	$58,592 $1.73 p/Share	33,868 Reduced 54.19%	28,632 Ordinary Shares
Jan 25 2021	BUY Grant, award, or other acquisition	-	62,500 Added 50.0%	62,500 Ordinary Shares
Sep 30 2020	SELL Open market or private sale	$92,053 $1.64 p/Share	56,130 Reduced 100.0%	0 Ordinary Shares

JMM

Judith M. Matthews

Chief Financial Officer

Dublin, L2

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ITRM shares.

Notify only if

Value

Insider Trading

Get notified when an Iterum Therapeutics PLC insider buys or sells ITRM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Iterum Therapeutics plc

Track Activities on ITRM

Account